CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.

Biotechnology

CureVac

CureVac's headquarters in Tübingen, Germany

Alexander Zehnder

Philipp Hofmann

Axel Sven Malkomes

Thaminda Ramanayake

Myriam Mendila

Ulrike Gnad-Vogt

Malte Greune

Quality Management Team

Clinical Development Team

Leadership Team

Biophysical Chemistry and Analytics Team

CureVac

Org chart

Teams

Quality Management Team

Clinical Development Team

Leadership Team

Biophysical Chemistry and Analytics Team

Offices

Similar companies